MARKET

ILMN

ILMN

Illumina
NASDAQ

Real-time Quotes | Nasdaq Last Sale

297.83
-0.39
-0.13%
Opening 12:52 11/14 EST
OPEN
299.56
PREV CLOSE
298.22
HIGH
300.24
LOW
294.91
VOLUME
227.86K
TURNOVER
--
52 WEEK HIGH
380.76
52 WEEK LOW
263.30
MARKET CAP
43.78B
P/E (TTM)
45.73
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ILMN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ILMN News

  • EBS or ILMN: Which Is the Better Value Stock Right Now?
  • Zacks.1d ago
  • Fulgent Genetics' Impressive Growth Acceleration Has Further To Run
  • Seeking Alpha - Article.1d ago
  • Cramer Weighs In On Nike, Beyond Meat And More
  • Benzinga.4d ago
  • Cramer Weighs In On Nike, Beyond Meat And More
  • Benzinga.4d ago

More

Industry

Advanced Medical Equipment & Technology
+0.17%
Healthcare Equipment & Supplies
+0.11%

Hot Stocks

Name
Price
%Change

About ILMN

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.
More

Webull offers Illumina, Inc. (ILMN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.